Download Free Sample Report

Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.

Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
This report aims to provide a comprehensive presentation of the global market for Cardiopulmonary Autotransfusion System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiopulmonary Autotransfusion System. This report contains market size and forecasts of Cardiopulmonary Autotransfusion System in global, including the following market information:

• Global Cardiopulmonary Autotransfusion System Market Revenue, 2018-2023, 2024-2029, ($ millions)
• Global Cardiopulmonary Autotransfusion System Market Sales, 2018-2023, 2024-2029, (K Units)

Global top five Cardiopulmonary Autotransfusion System companies in 2022 (%)
The global Cardiopulmonary Autotransfusion System market was valued at US$ 569 million in 2022 and is projected to reach US$ 667 million by 2029, at a CAGR of 2.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major players in global Cardiopulmonary Autotransfusion System market include Haemonetics, Medtronic, LivaNova, etc. The top 3 players occupy about 70% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Washed ATS is the main type, with a share about 90%. Heart Surgery is the main application, which holds a share about 35%.
We surveyed the Cardiopulmonary Autotransfusion System manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cardiopulmonary Autotransfusion System Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cardiopulmonary Autotransfusion System Market Segment Percentages, by Type, 2022 (%)

• Unwashed ATS
• Washed ATS

• Heart Surgery
• Great Organ Transplant Surgery
• Other Surgery

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

• Key companies Cardiopulmonary Autotransfusion System revenues in global market, 2018-2023 (Estimated), ($ millions)
• Key companies Cardiopulmonary Autotransfusion System revenues share in global market, 2022 (%)
• Key companies Cardiopulmonary Autotransfusion System sales in global market, 2018-2023 (Estimated), (K Units)
• Key companies Cardiopulmonary Autotransfusion System sales share in global market, 2022 (%)
• Further, the report presents profiles of competitors in the market, key players include:
• Haemonetics
• Medtronic
• LivaNova
• Fresenius Kabi
• Terumo
• Wandong Health Sources
• Outline of Major Chapters:
• Chapter 1: Introduces the definition of Cardiopulmonary Autotransfusion System, market overview.
• Chapter 2: Global Cardiopulmonary Autotransfusion System market size in revenue and volume.
• Chapter 3: Detailed analysis of Cardiopulmonary Autotransfusion System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
• Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
• Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
• Chapter 6: Sales of Cardiopulmonary Autotransfusion System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
• Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
• Chapter 8: Global Cardiopulmonary Autotransfusion System capacity by region & country.
• Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
• Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
• Chapter 11: The main points and conclusions of the report.